Study guide
2.5 Occupational, Environmental, & Travel Medicine in Canada
Medical Council of Canada Qualifying Examination Part I MCCQE Part I
Track your progress as you read
Finished sections get a check mark.
1 Chapter 1: Exam Overview, Blueprint & Canadian Medical Practice
1.1 MCCQE Part I Format, Scoring (439 Scale), & Strategy 1.2 The MCC Blueprint Matrix: Dimensions of Care & Physician Activities 1.3 Canadian Healthcare System, CanMEDS Roles, & Interprofessional Care 1.4 Evidence-Based Medicine, Study Design, & Clinical Statistics
2 Chapter 2: Population Health, Health Promotion & Preventive Care
2.1 Canadian Task Force on Preventive Health Care (CTFPHC) Screening Guidelines 2.2 Immunization Schedules (NACI) & Vaccine-Preventable Diseases across Lifespan 2.3 Disease Prevention, Lifestyle Counselling, & Harm Reduction 2.4 Outbreak Management, Disease Surveillance, & Infection Control 2.5 Occupational, Environmental, & Travel Medicine in Canada
3 Chapter 3: Internal Medicine — Cardiovascular & Respiratory Systems
3.1 Hypertension Canada 2020/2025 Guidelines, Dyslipidemia, & Primary Prevention 3.2 Ischemic Heart Disease, Acute Coronary Syndromes, & Heart Failure Management 3.3 Arrhythmias, Valvular Heart Disease, & Infective Endocarditis 3.4 Asthma, COPD, & Respiratory Failure (CTS Guidelines) 3.5 Thromboembolic Disease (DVT/PE), Pneumonia, & Pleural Effusions
4 Chapter 4: Internal Medicine — GI, Endocrine, Renal & Hematology/Oncology
4.1 Gastrointestinal Disorders, Acute Abdomen, & Liver/Biliary Disease 4.2 Diabetes Canada 2020/2025 Guidelines & Glycemic Management 4.3 Thyroid, Adrenal, Pituitary, & Electrolyte Disturbances 4.4 Acute Kidney Injury (AKI), Chronic Kidney Disease (CKD), & Nephrology 4.5 Hematology, Anemia Evaluation, Transfusion Medicine, & Common Cancers
5 Chapter 5: General Surgery, Orthopedics, & Emergency Care
5.1 Surgical Evaluation, Preoperative Clearance, & Postoperative Complications 5.2 Trauma Management (ATLS Protocol) & Burns 5.3 Acute Surgical Conditions (Appendicitis, Cholecystitis, Bowel Obstruction) 5.4 Fractures, Dislocations, Joint Pain, & Musculoskeletal Emergencies 5.5 Vascular Emergencies, Wound Care, & Shock Recognition
6 Chapter 6: Pediatrics & Adolescent Health
6.1 Pediatric Growth, Developmental Milestones, & Well-Child Examinations 6.2 Neonatal Resuscitation, Jaundice, & Common Congenital Anomalies 6.3 Pediatric Respiratory Emergencies (Croup, Bronchiolitis, Asthma) 6.4 Common Pediatric Infections, Exanthems, & Fever of Unknown Origin 6.5 Pediatric Abdominal Pain, Dehydration, & Fluid Management
7 Chapter 7: Obstetrics & Gynecology
7.1 Routine Antepartum Care, Screening, & Prenatal Diagnosis (SOGC Guidelines) 7.2 Medical Complications of Pregnancy (Preeclampsia, Gestational Diabetes, Infections) 7.3 Labor, Intrapartum Management, & Postpartum Complications/Hemorrhage 7.4 Abnormal Uterine Bleeding, Gynecologic Infections, & Contraception/Menopause 7.5 Gynecologic Oncology & Pelvic Mass Evaluation
8 Chapter 8: Psychiatry & Mental Health
8.1 Mood Disorders (Depression, Bipolar) & Suicide Risk Assessment 8.2 Anxiety Disorders, OCD, PTSD, & Somatic Symptom Disorders 8.3 Psychotic Disorders & Schizophrenia Management 8.4 Substance Use Disorders, Withdrawal Syndromes, & Harm Reduction 8.5 Pediatric, Perinatal, & Geriatric Psychiatry (Cognitive Impairment / Delirium)
9 Chapter 9: Neurology, Rheumatology, & Dermatology
9.1 Acute Stroke, TIA, & Neurovascular Emergencies 9.2 Headaches, Seizures, Movement Disorders, & Neuromuscular Disease 9.3 Inflammatory Arthritides (RA, Gout, SpA) & Systemic Autoimmune Diseases (SLE, Vasculitis) 9.4 Common Dermatologic Conditions, Cutaneous Manifestations of Systemic Disease, & Skin Cancers 9.5 Musculoskeletal Soft Tissue Injuries, Back Pain, & Physical Medicine
10 Chapter 10: Legal, Ethical, & Professional Behaviours in Canadian Practice
10.1 Informed Consent, Capacity Assessment, & Substitute Decision-Making (CMPA) 10.2 Medical Confidentiality, Privacy Laws (PIPEDA/PHIPA), & Disclosure of Harm 10.3 CMA Code of Ethics, Professionalism, & Physician Health/Boundary Issues 10.4 Mandatory Reporting (Child/Elder Abuse, Driving Safety, Fitness to Practice) & Quality/Safety
2.5 Occupational, Environmental, & Travel Medicine in Canada
Key Takeaways Explain This Topic AI
Pneumoconioses cause distinctive inhalational lung pathology: Asbestos affects lower lobes (pleural plaques, mesothelioma, synergistic smoking cancer risk), while Silica affects upper lobes (eggshell hilar calcifications, increased active TB risk).
Lead poisoning causes abdominal colic, motor neuropathy (wrist drop), basophilic stippling, and microcytic anemia; management requires exposure elimination and chelation (Succimer/EDTA).
Radon gas is the second leading cause of lung cancer in Canada (leading cause in non-smokers); testing and basement mitigation are key public health measures.
Mefloquine malaria prophylaxis is strictly contraindicated in patients with psychiatric disorders, seizure disorders, or cardiac conduction defects.
High-altitude illness prevention relies on gradual ascent and Acetazolamide; HACE requires immediate descent and Dexamethasone, while HAPE requires descent and Supplemental O2 / Nifedipine.
Last updated: July 2026
Occupational, Environmental, & Travel Medicine in Canada
Occupational health, environmental pathology, and travel medicine represent high-yield clinical topics on the MCCQE Part I . Canadian physicians must recognize work-related exposures, environmental toxins, and pre-travel prophylaxis protocols.
Occupational Pulmonary Diseases (Pneumoconioses)
Pneumoconioses are chronic fibrotic lung diseases caused by inhalation of inorganic dust particles in occupational environments.
Asbestos Exposure & Asbestosis
Occupations: Shipbuilding, insulation installation, building demolition, brake lining manufacture, pipefitting.
Pathology & Latency: Inhalation of asbestos fibers causes diffuse interstitial pulmonary fibrosis. Latency period is 20 to 30 years .
Clinical Presentation: Progressive exertional dyspnea, dry cough, fine bibasilar end-inspiratory crackles, digital clubbing.
Radiology: Lower lobe predominance of reticular opacities, pleural thickening, and calcified diaphragmatic pleural plaques (pathognomonic).
Associated Malignancies:
Bronchogenic Carcinoma: Most common malignancy associated with asbestos. Exposure to asbestos combined with cigarette smoking produces a multiplicative (synergistic) increase in lung cancer risk (up to 50-fold).
Malignant Mesothelioma: Tumor of pleural or peritoneal mesothelium highly specific to asbestos exposure (does not correlate with smoking).
Silica Exposure & Silicosis
Occupations: Hard-rock mining, sandblasting, quarrying, stonecutting, foundry work, glass manufacturing.
Radiology: Upper lobe nodular opacities and "eggshell calcification" of hilar lymph nodes .
CRITICAL EXAM PEARL: Silicosis impairs alveolar macrophage phagocytic function, markedly increasing susceptibility to active Mycobacterium tuberculosis (TB) infection. Patients diagnosed with silicosis must undergo routine annual Tuberculin Skin Testing (TST) or Interferon-Gamma Release Assay (IGRA).
Occupational Asthma
Epidemiology: Variable airway hyperresponsiveness caused by workplace agents (e.g., isocyanates in polyurethane paints/spray foams, flour dust in bakers, grain dust, animal dander).
Diagnostic Feature: Symptoms (wheezing, dyspnea, chest tightness) improve on weekends and vacations . Diagnosed by serial Peak Expiratory Flow Rate (PEFR) logs at work versus home.
- Environmental & Heavy Metal Toxicities
- Lead Poisoning (Plumbism)
Exposures: Demolition of old painted structures, battery manufacturing, radiator repair, lead smelting, lead water pipes.
Clinical Presentation:
Gastrointestinal: Severe abdominal colic, constipation, nausea.
Neurological: Peripheral motor neuropathy presenting as wrist drop (radial nerve palsy), extensor weakness, cognitive impairment, memory loss.
Hematologic: Microcytic hypochromic anemia with characteristic basophilic stippling on peripheral blood smear.
Blue Lead Lines (Burton Lines): Hyperpigmented bluish line along the gingival margin.
Diagnostic Test: Venous blood lead level (BLL).
Management: Remove from source. Chelation therapy: Oral Succimer (DMSA) for moderate levels; Calcium Disodium EDTA + Dimercaprol (BAL) for severe encephalopathy.
Carbon Monoxide (CO) Toxicity
Exposures: Faulty residential gas furnaces, space heaters, motor vehicle exhaust in enclosed spaces, house fires.
Pathophysiology: CO binds hemoglobin with 200x greater affinity than oxygen, forming carboxyhemoglobin (COHb). This shifts the oxygen-hemoglobin dissociation curve to the LEFT , severely impairing peripheral tissue oxygen unloading.
Clinical Presentation: Headache, dizziness, confusion, nausea, ataxia, seizures, coma. Classic "cherry-red skin" is rare in living patients.
Diagnosis: Arterial or venous blood carboxyhemoglobin (COHb) level . Standard pulse oximetry is misleadingly normal because it cannot distinguish COHb from oxyhemoglobin.
Management:
Administer 100% normobaric oxygen via non-rebreather mask (reduces COHb half-life from 320 to 80 minutes).
Hyperbaric Oxygen (HBO) Indications: COHb >25% (>15% in pregnant women), loss of consciousness, neurological deficits, severe metabolic acidosis, or cardiac ischemia.
Radon Gas Exposure
Public Health Impact: Radon is a naturally occurring radioactive gas produced by the decay of uranium in soil and rock. It is the second leading cause of lung cancer in Canada overall, and the #1 cause of lung cancer among non-smokers .
Mitigation: Gas enters homes through basement cracks. Testing with long-term detectors is recommended; mitigation (sub-slab depressurization) is indicated if levels exceed 200 Bq/m³ .
- Travel Medicine & High-Altitude Illness
- Malaria Chemoprophylaxis
Selection depends on geographic destination, regional resistance patterns, host co-morbidities, and pregnancy status.
Medication Schedule & Timing Contraindications & Adverse Effects
Atovaquone-Proguanil (Malarone) Daily; Start 1-2 days pre-travel, daily during, 7 days post-travel Contraindicated in severe renal impairment (CrCl <30 mL/min); well tolerated
Doxycycline Daily; Start 1-2 days pre-travel, daily during, 4 weeks post-travel Photosensitivity, esophageal ulceration, pill esophagitis; contraindicated in pregnancy & children <8 years
Mefloquine Weekly; Start 2-3 weeks pre-travel, weekly during, 4 weeks post-travel STRICTLY CONTRAINDICATED in: ; 1. Active or past psychiatric disorders (depression, psychosis, anxiety); 2. Seizure disorders; 3. Cardiac conduction abnormalities
Traveler's Diarrhea Management
Prevention: Dietary vigilance ("Boil it, cook it, peel it, or forget it").
Mild/Moderate TD: Oral Rehydration Salts (ORS) and loperamide.
Severe / Dysenteric TD (Fever, Bloody Stools): Azithromycin is the first-line antibiotic choice (especially for travel to South/Southeast Asia due to high fluoroquinolone-resistant Campylobacter ).
Contraindication: Do NOT administer anti-motility agents (loperamide) to patients presenting with high fever or bloody diarrhea (risk of toxic megacolon).
High-Altitude Illness
Occurs during travel to altitudes >2,500 meters without adequate acclimatization.
Acute Mountain Sickness (AMS): Headache plus nausea, dizziness, fatigue, or insomnia. Prevention/Treatment: Acetazolamide (carbonic anhydrase inhibitor; induces renal bicarbonate excretion, causing metabolic acidosis that stimulates hyperventilation and speeds acclimatization).
High-Altitude Cerebral Edema (HACE): Severe progression marked by ataxia, confusion, and altered mental status. Medical emergency. Management: Immediate descent , supplemental oxygen, and Dexamethasone .
High-Altitude Pulmonary Edema (HAPE): Non-cardiogenic pulmonary edema causing dyspnea at rest, cough, cyanosis, and pink frothy sputum. Management: Immediate descent , supplemental oxygen, and Nifedipine (or Sildenafil).
Exam Trap: On the MCCQE Part I, if a traveler bound for a malaria-endemic region has a history of major depression, generalized anxiety disorder, or epilepsy , Mefloquine is strictly contraindicated . Select Atovaquone-proguanil or Doxycycline.
Clinical Scenario: A 42-year-old hard-rock miner with a 20-year history of underground silica exposure presents for an occupational health exam. His chest X-ray reveals multiple upper lobe nodular opacities and hilar lymph node eggshell calcification. He is asymptomatic. What essential preventive screening test must be performed annually?
Answer: Tuberculin Skin Test (TST) or Interferon-Gamma Release Assay (IGRA) screening for Tuberculosis. Silicosis severely impairs alveolar macrophage function, resulting in a significantly elevated risk of developing active Mycobacterium tuberculosis infection.